The Global Hepatitis C Virus (HCV) Testing Industry is expected to reach US$ 785.3 million by 2023, signaling significant expansion. Projections for the period 2023-2033 predict a significant Compound Annual Growth Rate (CAGR) of 5.4%, with the market anticipated to reach a valuation of US$ 1,326.7 million. This trend corresponds to a strong value CAGR …